As per the latest Enforcement Report by the US health regulator, Lupin Pharmaceuticals Inc, a US-based arm of the Mumbai-based drug major, is recalling the affected lot due to "Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study."from Healthcare/Biotech-Industry-Economic Times https://ift.tt/RKxGOUu
via IFTTT
0 comments:
Post a Comment